Modernizing Nuclear Plants And SMR Advances Will Create Future Opportunities

AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Published
21 Mar 25
Updated
08 Aug 25
AnalystConsensusTarget's Fair Value
US$22.20
3.3% undervalued intrinsic discount
08 Aug
US$21.47
Loading
1Y
112.4%
7D
-3.9%

Author's Valuation

US$22.2

3.3% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on04 Aug 25
Fair value Increased 7.77%

The notable increase in Mirion Technologies’ future P/E and simultaneous decline in net profit margin suggest higher valuation expectations despite weaker profitability, leading analysts to raise the price target from $20.60 to $22.20. What's in the News Mirion Technologies raised full-year 2025 revenue growth guidance to 7.0%-9.0% (from 5.0%-7.0% prior), factoring in a foreign exchange and acquisition tailwind, but trimmed organic growth expectations due to weakness in Labs & Research and Dosimetry markets.

Shared on01 May 25
Fair value Increased 38%

Shared on24 Apr 25
Fair value Decreased 22%

AnalystConsensusTarget has increased shares outstanding growth rate from 0.0% to 0.1%.

Shared on17 Apr 25
Fair value Decreased 5.15%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 2.04%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 0.34%

Shared on26 Mar 25
Fair value Increased 4.74%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.